Peringkat dalam Saham
#28091
HeraMED Limited and its associated entities are dedicated to the design,... HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Kapitalisasi Pasar
$28.60M
Perubahan (1 hari)
-5.41%
Perubahan (1 tahun)
53.47%
Perdagangan HeraMED Limited (HMD)
Harga HMD dengan kapitalisasi pasar B
Kapitalisasi pasar dari HeraMED Limited(HMD)
Kapitalisasi Pasar: $28.60M
Per August 2026, HeraMED Limited memiliki kapitalisasi pasar sebesar $28.60M. Ini menjadikan HeraMED Limited sebagai perusahaan 28091st paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar HeraMED Limited dari 2018 hingga 2026
HMD dibandingkan dengan 5 teratas stocks paling populer
| Harga HMD |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.301T
|
+18,532,557.18%
|
|
|
|
|
$4.634T
|
+16,200,622.01%
|
|
|
|
|
$4.143T
|
+14,484,403.83%
|
|
|
|
|
$3.589T
|
+12,548,904.24%
|
|
|
|
|
$2.857T
|
+9,988,235.83%
|
